D-0293-2015 Class II Terminated

Recalled by Baxter Healthcare Corp. — Deerfield, IL

FDA drug recall D-0293-2015 was initiated by Baxter Healthcare Corp. on Apr 24, 2014 and is designated Class II. Reason for recall: Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed… The recall status is terminated (terminated Jun 16, 2015). Affected quantity: 19,152 Containers.

Recall Details

Product Type
Drugs
Report Date
Dec 17, 2014
Initiation Date
Apr 24, 2014
Termination Date
Jun 16, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,152 Containers

Product Description

Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.

Reason for Recall

Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.

Distribution Pattern

Nationwide

Code Information

Lot #: NC082768, Exp 12/23/2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0293-2015
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.